The Hong Kong Aisai'er Special Medical Food R&D and Production Base Project has been established in the Central Plains Medical Science City.

On February 24, 2025, the signing ceremony for the establishment of the Hong Kong Aisai'er Special Medical Food R&D and Production Base Project in the Central Plains Medical Science City took place in the Zhengzhou Airport Economic Zone, Henan Province. Qin Xindong, Director of the Medical Science City Management Committee, and Zeng Chenghui, a shareholder of Hong Kong Aisai'er Co., Ltd., signed the agreement on behalf of both parties and held discussions.

Qin Xindong warmly welcomed the visiting delegation from Hong Kong Aisai'er Co., Ltd., led by Zeng Chenghui. He pointed out that the Central Plains Medical Science City is experiencing rapid development, with a highly concentrated industrial resource base and broad prospects for future growth. He noted that Hong Kong Aisai'er’s decision to establish an R&D and production base in the area reflects its strong confidence in the city’s development potential and investment environment. He emphasized that this cooperation marks a promising beginning for both parties to work together and achieve mutual success.

Zeng Chenghui stated that Hong Kong Aisai’er possesses advanced technology, extensive experience, and excellent R&D capabilities in the field of special medical foods. He noted that the company’s products and philosophy have received widespread recognition within the industry. He added that the Central Plains Medical Science City is developing at an impressive pace and is poised to become an internationally influential hub for medical innovation and a world-class highland for the biomedical and health industry.

The Hong Kong Aisai'er Special Medical Food R&D and Production Base project will include two production lines for powders and emulsions. Over the next five years, the company plans to obtain no fewer than 15 product approvals for special medical foods.

Some shareholders of Hong Kong Aisai'er Co., Ltd., relevant officials from the Medical Science City Management Committee, and leaders from the Port Investment Grand Health Group attended the meeting and witnessed the signing ceremony.